For use by adult smokers only. Follow advice from your doctor or pharmacist at all times.
The goal is simple: stop smoking and save lives
Smoking remains the leading cause of preventable death and disease in Australia, driving chronic illness, reduced quality of life, and premature mortality.
Combustible tobacco exposes the body to thousands of toxic chemicals created through burning—many of which are directly linked to cancer, cardiovascular disease, and respiratory conditions.
The impact of smoking combustible tobacco is significant. Smoking is:
Combustible tobacco exposes the body to thousands of toxic chemicals created through burning—many of which are directly linked to cancer, cardiovascular disease, and respiratory conditions.
The impact of smoking combustible tobacco is significant. Smoking is:
- Responsible for around 90% of lung cancer cases¹.
- A major contributor to chronic diseases including heart disease, 16 types of cancer, and COPD
- Affiliated with progressive decline in health, reduced physical capacity, poorer outcomes later in life, and premature mortality².
- Associated with an estimated 10-year reduction in life expectancy³.
66 Australians die from smoking-related illness every-day¹.
Encouragingly, evidence consistently shows that stopping smoking at any stage reduces the risk of serious disease and premature death, with earlier cessation associated with greater improvements in life expectancy.
Even after years of smoking, meaningful health gains remain achievable.
Even after years of smoking, meaningful health gains remain achievable.
References:
1. Cancer Council. Cancer Information, Smoking, Smoking is the most preventable cause of cancer in Australia.
2. Doll, R, Peto, R, et al. Mortality in relation to smoking: 50 Years’ observations on male British doctors. the BMJ. 2004
3. Bates, C. Tobacco harm reduction: evidence briefs for policymakers. The Counterfactual. 2025
1. Cancer Council. Cancer Information, Smoking, Smoking is the most preventable cause of cancer in Australia.
2. Doll, R, Peto, R, et al. Mortality in relation to smoking: 50 Years’ observations on male British doctors. the BMJ. 2004
3. Bates, C. Tobacco harm reduction: evidence briefs for policymakers. The Counterfactual. 2025
Quitting often takes more than willpower
Nicotine dependence, behavioural habits, and environmental triggers make smoking cessation challenging.
Most smokers do not succeed on their first attempt. Many individuals require multiple quit attempts, with some estimates suggesting 30 or more attempts.
The vast majority of smokers take multiple attempts to quit smoking, many of which give up without success. In fact, for many people who smoke, it may take 30 or more quit attempts to quit before achieving long-term success⁴. The majority of quit attempts are made without structured support.
Unassisted quitting (the “cold turkey” method) remains common—but has low long-term success rates. Only 3–5% of smokers remain abstinent beyond six months when attempting to quit without support⁵.
Outcomes improve significantly when evidence-based interventions are used.
Despite this, many smokers continue to struggle to find an approach that works for them—highlighting the need for additional, effective options within a structured treatment framework.
Most smokers do not succeed on their first attempt. Many individuals require multiple quit attempts, with some estimates suggesting 30 or more attempts.
The vast majority of smokers take multiple attempts to quit smoking, many of which give up without success. In fact, for many people who smoke, it may take 30 or more quit attempts to quit before achieving long-term success⁴. The majority of quit attempts are made without structured support.
Unassisted quitting (the “cold turkey” method) remains common—but has low long-term success rates. Only 3–5% of smokers remain abstinent beyond six months when attempting to quit without support⁵.
Outcomes improve significantly when evidence-based interventions are used.
Despite this, many smokers continue to struggle to find an approach that works for them—highlighting the need for additional, effective options within a structured treatment framework.
Supporting better outcomes with evidence-based care
|
Clinical guidance now recognises Nicotine Vaping Products (NVPs) as a potential option for adults who have not achieved success with existing quitting methods.
A growing body of research has explored the role of NVPs in smoking cessation.
NVPS provide Smokers with high-quality Tobacco Harm Reduction products with the aim to:
These findings highlight the potential role of NVPs as part of a broader harm reduction strategy. |
|
Research indicates the use of NVPs is around 3 Time More Effective then existing nicotine replacement therapies⁷.
References
6. Latest Cochrane Review finds high certainty evidence that nicotine e-cigarettes are more effective than traditional nicotine-replacement therapy (NRT) in helping people quit smoking. Cochrane. 2022.
7. Vaping more effective at helping socially disadvantaged people quit smoking than NRT. UNSW Sydney. 2025.
8. Bates, C. Tobacco harm reduction: evidence briefs for policymakers. The Counterfactual. 2025.
6. Latest Cochrane Review finds high certainty evidence that nicotine e-cigarettes are more effective than traditional nicotine-replacement therapy (NRT) in helping people quit smoking. Cochrane. 2022.
7. Vaping more effective at helping socially disadvantaged people quit smoking than NRT. UNSW Sydney. 2025.
8. Bates, C. Tobacco harm reduction: evidence briefs for policymakers. The Counterfactual. 2025.
NicoZed® - A Better Smoking Cessation Choice
NicoZed® has been developed specifically for the Australian healthcare environment, with a focus on supporting smoking cessation through a structured and controlled approach.
|
Regulated to Australian Standards
Manufactured in accordance with stringent Australian regulatory requirements, including TGA product standards for quality, pharmaceutical-grade ingredients, safety, and consistency. |
Prescription-Only Access
Available exclusively via prescription, supporting use under the guidance of a healthcare professional as part of a structured cessation plan. |
Designed for Smoking Cessation
Developed to support adult smokers transitioning away from combustible tobacco within a harm reduction framework. A structured step-down system supports gradual reduction in nicotine dependence. |
|
Controlled Nicotine Delivery
Delivers consistent nicotine delivery to help manage cravings and reduce withdrawal symptoms without the harmful byproducts of combustion. |
Supports Behavioural Change
Addresses both nicotine dependence and the behavioural aspects of smoking, including habitual hand-to-mouth action. |
NFC-Enabled Tracking
Integrated NFC technology allows access to usage data, supporting awareness, accountability, and progress tracking over time. |
The NicoZed® NVP Product Range
The NicoZed® system integrates device technology and nicotine formulations within a regulated framework, supporting controlled delivery and step-down reduction.
NicoZed® DeviceDesigned for controlled nicotine delivery and usage tracking.
|
NicoZed® PodsAvailable in regulated nicotine strengths and a range of flavours to support step-down reduction.
|
The NicoZed® System
A step-by-step pathway to quitting smoking
Reduce nicotine dependence over time—with structure, support, and control
Quitting smoking doesn’t happen all at once. A gradual, structured reduction in nicotine can make the process more manageable and can lead to more long term success.
The NicoZed® system supports a step-down approach, helping users progressively reduce dependence while maintaining control over cravings and habits.
Quitting smoking doesn’t happen all at once. A gradual, structured reduction in nicotine can make the process more manageable and can lead to more long term success.
The NicoZed® system supports a step-down approach, helping users progressively reduce dependence while maintaining control over cravings and habits.
This structured progression allows for:
- Gradual reduction in nicotine dependence
- Ongoing management of cravings
- Time to address behavioural habits associated with smoking
Use should be guided by a healthcare professional as part of a broader smoking cessation plan.
About ArixlYour trusted pharmaceutical supply and Tobacco Harm Reduction partner in Australia
Arixl is a specialised pharmaceutical supply company supporting pharmacies, doctors, and healthcare providers across Australia with reliable and compliant healthcare solutions.
With a focus on smoking cessation and Tobacco Harm Reduction (THR), Arixl works to improve access to regulated therapeutic options that support healthcare professionals in addressing one of the most significant preventable causes of death and disease. We partner with healthcare providers to deliver consistent supply, regulatory assurance, and practical support across the full healthcare supply chain. |
|
Regulatory & Medical Information
NicoZed® is a nicotine vaping product intended for use as part of a structured smoking cessation plan under the supervision of a qualified healthcare professional.
This website provides general information relating to smoking cessation, nicotine dependence, and harm reduction. It is not intended to provide medical advice, diagnosis, or treatment, and should not be relied upon as a substitute for professional healthcare guidance.
Nicotine vaping products should only be used in accordance with applicable Australian regulations and where clinically appropriate, as determined by a registered medical practitioner or pharmacist.
Smoking cessation outcomes vary between individuals. No guarantee is made regarding the effectiveness of any product or approach described on this website.
All content is provided in good faith and is believed to be accurate at the time of publication. However, no representation or warranty is given as to its completeness, accuracy, or ongoing relevance.
Users are encouraged to consult a healthcare professional to determine the most appropriate cessation strategy for their individual circumstances.
This website is intended for adults aged 18 years and over.
NicoZed® is a nicotine vaping product intended for use as part of a structured smoking cessation plan under the supervision of a qualified healthcare professional.
This website provides general information relating to smoking cessation, nicotine dependence, and harm reduction. It is not intended to provide medical advice, diagnosis, or treatment, and should not be relied upon as a substitute for professional healthcare guidance.
Nicotine vaping products should only be used in accordance with applicable Australian regulations and where clinically appropriate, as determined by a registered medical practitioner or pharmacist.
Smoking cessation outcomes vary between individuals. No guarantee is made regarding the effectiveness of any product or approach described on this website.
All content is provided in good faith and is believed to be accurate at the time of publication. However, no representation or warranty is given as to its completeness, accuracy, or ongoing relevance.
Users are encouraged to consult a healthcare professional to determine the most appropriate cessation strategy for their individual circumstances.
This website is intended for adults aged 18 years and over.
Helping people live longer, better lives
ABN: 46 675 952 306 © 2026 by Arixl Pty Ltd All Rights Reserved Proudly created by Adessa Design |
Contact Us
(03) 5929 8948 geoff.m@arixl.com.au Mon - Fri - 9AM–5PM EST Australia Quick Links Home | About NicoZed® | The NicoZed® System | Product Range Help & Support | Product Recourses | Help Quitting Smoking Healthcare Professionals | T's & C's | Contact Us Supply is restricted to licensed healthcare professionals and approved organisations. |
Age Verification
Are you 18 years of age or older?
You must be 18 years or older to access this website.
This content is only visible to confirmed adults (18+).